SK Square Co., Ltd.
402340.KS · KSC
Market closed1,177,000.00-35,000.00 (-2.89%)
Key statistics
Previous close1,212,000.00
Open1,127,000.00
Day high1,239,000.00
Day low1,116,000.00
52-week high2,189,000.00
52-week low130,900.00
Market cap155.14T
Volume784.01K
Average volume1.07M
P/E ratio9.97
Forward P/E—
EPS118.08K
Dividend yield+0.13%
Market context
Why it moved
In the absence of directly relevant news, the sharp double-digit decline in 402340.KS (SK Biopharmaceuticals or related KRX-listed entity) appears to be driven by broad negative market sentiment or a company-specific adverse development such as disappointing earnings results or a failed clinical/regulatory milestone that triggered heavy selling pressure.
What is happening
Recent company-specific developments and publisher coverage.
BigGo Finance · July 13, 2026'2 Million Won Niks' Collapses… SK Hynix Plunges 10% Despite ADR TailwindBigGo Finance · July 6, 2026SK Hynix Nasdaq ADR Listing Imminent; SK Square Eyes approximately $29 Billion Value RevaluationSeoul Economic Daily · July 2, 2026SK Square Set to Gain from SK hynix Nasdaq Listing매일경제 · July 1, 2026SK Square is drawing attention as SK Hynix's listing of the US Stock Deposit Certificate (ADR) is be..marketscreener.com · June 30, 2026Tranche Update on SK Square Co., Ltd.'s Equity Buyback Plan announced on March 25, 2026.Seoul Economic Daily · June 23, 2026SK Square Tops 2.2 Million Won in Premarket on SK hynix RallyChosunbiz · June 23, 2026SK Square jumps as market reassesses SK hynix stake on ADR plan - CHOSUNBIZSeoul Economic Daily · April 30, 2026NH Investment Raises SK Square Target Price to 1.1 Million Won Mt Newswire · June 26, 2026SK Hynix Eyes to Raise KRW45.5 Trillion Through Nasdaq Listing; Shares Decline 9%